GlassScriptPhysician profile
Kathleen May Bailey
NPI 1578538823
$1,449.35
in general payments reported to CMS, 2019-2025
24 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.16 · 2020: $68.69 · 2021: $221 · 2022: $250 · 2023: $313 · 2024: $313 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.24 |
| Education | $139.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $196.04 | 2023-2025 | Veozah |
| Organon LLC | $195.24 | 2022-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $147.70 | 2021-2024 | Gardasil 9, Gardasil |
| Abbvie INC. | $111.11 | 2020-2022 | |
| Hologic Sales and Service, LLC | $83.40 | 2019-2022 | |
| Sage Therapeutics, LLC | $80.60 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $77.68 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $59.44 | 2025 | |
| Acessa Health INC. | $54.88 | 2021 | |
| Evofem Biosciences, INC. | $49.63 | 2020-2021 | |
| Medtronic, INC. | $48.77 | 2022 | |
| Exeltis, USA INC. | $45.81 | 2021-2023 | Slynd |
| Smith+Nephew, INC. | $41.07 | 2023-2024 | Stravix, Stravix Pl |
| Coopersurgical, INC. | $36.21 | 2021-2024 | Paragard T 380a |
| Myovant Sciences INC. | $35.26 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $29.12 | 2023 | Evenity |
| Mimedx Group, INC. | $28.58 | 2025 | |
| Duchesnay USA Incorporated | $24.01 | 2019 | |
| Terumo Medical Corporation | $21.75 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $20.45 | 2025 | |
| Exact Sciences Corporation | $17.23 | 2023 | Cologuard Collection Kit |
| Millicent US INC | $15.80 | 2025 | Femlyv, Intrarosa |
| Becton, Dickinson and Company | $15.38 | 2022 | |
| Pfizer INC. | $14.19 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.